CME Group Inc. (NASDAQ:CME – Get Rating) – Jefferies Financial Group raised their Q2 2022 earnings per share estimates for CME Group in a report issued on Monday, July 11th. Jefferies Financial Group analyst D. Fannon now anticipates that the financial services provider will earn $1.90 per share for the quarter, up from their previous forecast of $1.87. Jefferies Financial Group currently has a “Buy” rating and a $267.00 price objective on the stock. The consensus estimate for CME Group’s current full-year earnings is $7.91 per share. Jefferies Financial Group also issued estimates for CME Group’s Q3 2022 earnings at $1.81 EPS, Q4 2022 earnings at $1.87 EPS, FY2022 earnings at $7.71 EPS, Q3 2023 earnings at $1.98 EPS, Q4 2023 earnings at $2.07 EPS, Q1 2024 earnings at $2.32 EPS and FY2024 earnings at $8.78 EPS.
Other equities research analysts also recently issued research reports about the company. Raymond James lowered their price objective on CME Group from $254.00 to $235.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 6th. Oppenheimer raised CME Group from a “market perform” rating to an “outperform” rating and set a $223.00 target price on the stock in a research note on Wednesday, May 25th. Atlantic Securities raised CME Group from a “neutral” rating to an “overweight” rating and set a $235.00 target price on the stock in a research note on Friday, June 10th. UBS Group reduced their target price on CME Group from $258.00 to $246.00 and set a “buy” rating on the stock in a research note on Wednesday, July 6th. Finally, Argus raised CME Group from a “hold” rating to a “buy” rating in a research note on Monday, May 16th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $242.20.
Shares of CME stock opened at $203.55 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52-week low of $185.79 and a 52-week high of $256.94. The company has a market capitalization of $73.16 billion, a PE ratio of 26.57, a price-to-earnings-growth ratio of 4.30 and a beta of 0.44. The business’s fifty day moving average is $201.54 and its 200 day moving average is $222.54.
CME Group (NASDAQ:CME – Get Rating) last issued its quarterly earnings data on Wednesday, April 27th. The financial services provider reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.00 by $0.11. CME Group had a return on equity of 9.29% and a net margin of 57.98%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the business posted $1.79 earnings per share. The firm’s revenue was up 7.4% compared to the same quarter last year.
Hedge funds have recently modified their holdings of the company. Bromfield Sneider Wealth Advisors bought a new position in CME Group in the 1st quarter worth $26,000. J.W. Cole Advisors Inc. purchased a new stake in shares of CME Group during the 1st quarter valued at about $26,000. Power Corp of Canada purchased a new stake in shares of CME Group during the 1st quarter valued at about $26,000. IndexIQ Advisors LLC purchased a new stake in shares of CME Group during the 1st quarter valued at about $27,000. Finally, Cornerstone Advisory LLC purchased a new stake in shares of CME Group during the 4th quarter valued at about $29,000. 86.71% of the stock is owned by hedge funds and other institutional investors.
The business also recently announced a quarterly dividend, which was paid on Monday, June 27th. Shareholders of record on Friday, June 10th were paid a dividend of $1.00 per share. The ex-dividend date of this dividend was Thursday, June 9th. This represents a $4.00 dividend on an annualized basis and a yield of 1.97%. CME Group’s dividend payout ratio is presently 52.22%.
About CME Group (Get Rating)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.